 
													 
													 
																									ViiV Healthcare has announced that its long-acting HIV pre-exposure prophylaxis (PrEP) therapy, cabotegravir, demonstrated superior acceptability among patients compared to Gilead Sciences‘ lenacapavir in an early-stage...
 
													 
													 
																									The Interlake–Eastern Regional Health Authority (IERHA) is expanding its services in response to a significant rise in measles cases in the region. At the annual general...
 
													 
													 
																									The Prairie Mountain Health region in Manitoba has experienced a significant rise in HIV cases, escalating from just six reported cases in 2022 to a startling...